nodes	percent_of_prediction	percent_of_DWPC	metapath
Ivacaftor—ABCB1—peripheral nervous system neoplasm	0.504	1	CbGaD
Ivacaftor—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0586	0.167	CbGbCtD
Ivacaftor—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0586	0.167	CbGbCtD
Ivacaftor—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0406	0.116	CbGbCtD
Ivacaftor—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0351	0.1	CbGbCtD
Ivacaftor—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0326	0.0931	CbGbCtD
Ivacaftor—ABCB1—Vincristine—peripheral nervous system neoplasm	0.025	0.0713	CbGbCtD
Ivacaftor—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.0233	0.0665	CbGbCtD
Ivacaftor—ABCB1—Etoposide—peripheral nervous system neoplasm	0.0229	0.0654	CbGbCtD
Ivacaftor—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.0156	0.0446	CbGbCtD
Ivacaftor—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.015	0.0427	CbGbCtD
Ivacaftor—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0137	0.0392	CbGbCtD
Ivacaftor—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00936	0.0267	CbGbCtD
Ivacaftor—Pleuritic pain—Topotecan—peripheral nervous system neoplasm	0.008	0.0549	CcSEcCtD
Ivacaftor—Blood glucose increased—Isotretinoin—peripheral nervous system neoplasm	0.00311	0.0213	CcSEcCtD
Ivacaftor—Blood glucose increased—Tretinoin—peripheral nervous system neoplasm	0.00311	0.0213	CcSEcCtD
Ivacaftor—Bilirubin total increased—Epirubicin—peripheral nervous system neoplasm	0.00263	0.018	CcSEcCtD
Ivacaftor—Transaminases increased—Melphalan—peripheral nervous system neoplasm	0.00259	0.0177	CcSEcCtD
Ivacaftor—Bilirubin total increased—Doxorubicin—peripheral nervous system neoplasm	0.00244	0.0167	CcSEcCtD
Ivacaftor—Blood glucose increased—Alitretinoin—peripheral nervous system neoplasm	0.00236	0.0162	CcSEcCtD
Ivacaftor—Mastitis—Epirubicin—peripheral nervous system neoplasm	0.00216	0.0148	CcSEcCtD
Ivacaftor—Hyperaesthesia—Tretinoin—peripheral nervous system neoplasm	0.00203	0.0139	CcSEcCtD
Ivacaftor—Hyperaesthesia—Isotretinoin—peripheral nervous system neoplasm	0.00203	0.0139	CcSEcCtD
Ivacaftor—Mastitis—Doxorubicin—peripheral nervous system neoplasm	0.002	0.0137	CcSEcCtD
Ivacaftor—Blood bilirubin increased—Topotecan—peripheral nervous system neoplasm	0.0017	0.0116	CcSEcCtD
Ivacaftor—Blood bilirubin increased—Tretinoin—peripheral nervous system neoplasm	0.00168	0.0115	CcSEcCtD
Ivacaftor—Blood bilirubin increased—Isotretinoin—peripheral nervous system neoplasm	0.00168	0.0115	CcSEcCtD
Ivacaftor—Wheezing—Tretinoin—peripheral nervous system neoplasm	0.00155	0.0106	CcSEcCtD
Ivacaftor—Wheezing—Isotretinoin—peripheral nervous system neoplasm	0.00155	0.0106	CcSEcCtD
Ivacaftor—Hyperaesthesia—Alitretinoin—peripheral nervous system neoplasm	0.00154	0.0105	CcSEcCtD
Ivacaftor—Ear pain—Topotecan—peripheral nervous system neoplasm	0.00137	0.00937	CcSEcCtD
Ivacaftor—Musculoskeletal chest pain—Epirubicin—peripheral nervous system neoplasm	0.00136	0.00934	CcSEcCtD
Ivacaftor—Ear pain—Tretinoin—peripheral nervous system neoplasm	0.00136	0.00929	CcSEcCtD
Ivacaftor—Ear pain—Isotretinoin—peripheral nervous system neoplasm	0.00136	0.00929	CcSEcCtD
Ivacaftor—Blood bilirubin increased—Alitretinoin—peripheral nervous system neoplasm	0.00128	0.00875	CcSEcCtD
Ivacaftor—Nasal congestion—Tretinoin—peripheral nervous system neoplasm	0.00127	0.0087	CcSEcCtD
Ivacaftor—Nasal congestion—Isotretinoin—peripheral nervous system neoplasm	0.00127	0.0087	CcSEcCtD
Ivacaftor—Musculoskeletal chest pain—Doxorubicin—peripheral nervous system neoplasm	0.00126	0.00864	CcSEcCtD
Ivacaftor—Wheezing—Alitretinoin—peripheral nervous system neoplasm	0.00117	0.00804	CcSEcCtD
Ivacaftor—Aspartate aminotransferase increased—Topotecan—peripheral nervous system neoplasm	0.00105	0.0072	CcSEcCtD
Ivacaftor—Nasopharyngitis—Tretinoin—peripheral nervous system neoplasm	0.00103	0.00709	CcSEcCtD
Ivacaftor—Nasopharyngitis—Isotretinoin—peripheral nervous system neoplasm	0.00103	0.00709	CcSEcCtD
Ivacaftor—Ear pain—Alitretinoin—peripheral nervous system neoplasm	0.00103	0.00704	CcSEcCtD
Ivacaftor—Wheezing—Cisplatin—peripheral nervous system neoplasm	0.000999	0.00685	CcSEcCtD
Ivacaftor—Nasal congestion—Alitretinoin—peripheral nervous system neoplasm	0.000962	0.0066	CcSEcCtD
Ivacaftor—Upper respiratory tract infection—Isotretinoin—peripheral nervous system neoplasm	0.000929	0.00637	CcSEcCtD
Ivacaftor—Upper respiratory tract infection—Tretinoin—peripheral nervous system neoplasm	0.000929	0.00637	CcSEcCtD
Ivacaftor—Infestation—Topotecan—peripheral nervous system neoplasm	0.000899	0.00616	CcSEcCtD
Ivacaftor—Infestation NOS—Topotecan—peripheral nervous system neoplasm	0.000899	0.00616	CcSEcCtD
Ivacaftor—Infestation—Tretinoin—peripheral nervous system neoplasm	0.000891	0.00611	CcSEcCtD
Ivacaftor—Infestation NOS—Isotretinoin—peripheral nervous system neoplasm	0.000891	0.00611	CcSEcCtD
Ivacaftor—Infestation—Isotretinoin—peripheral nervous system neoplasm	0.000891	0.00611	CcSEcCtD
Ivacaftor—Infestation NOS—Tretinoin—peripheral nervous system neoplasm	0.000891	0.00611	CcSEcCtD
Ivacaftor—Transaminases increased—Epirubicin—peripheral nervous system neoplasm	0.000869	0.00595	CcSEcCtD
Ivacaftor—Aspartate aminotransferase increased—Dactinomycin—peripheral nervous system neoplasm	0.000851	0.00584	CcSEcCtD
Ivacaftor—Nasal congestion—Cisplatin—peripheral nervous system neoplasm	0.00082	0.00562	CcSEcCtD
Ivacaftor—Rhinitis—Topotecan—peripheral nervous system neoplasm	0.000809	0.00554	CcSEcCtD
Ivacaftor—Transaminases increased—Doxorubicin—peripheral nervous system neoplasm	0.000804	0.00551	CcSEcCtD
Ivacaftor—Nasopharyngitis—Alitretinoin—peripheral nervous system neoplasm	0.000784	0.00537	CcSEcCtD
Ivacaftor—Connective tissue disorder—Melphalan—peripheral nervous system neoplasm	0.000776	0.00532	CcSEcCtD
Ivacaftor—Aspartate aminotransferase increased—Vincristine—peripheral nervous system neoplasm	0.000761	0.00521	CcSEcCtD
Ivacaftor—Tinnitus—Isotretinoin—peripheral nervous system neoplasm	0.000746	0.00511	CcSEcCtD
Ivacaftor—Tinnitus—Tretinoin—peripheral nervous system neoplasm	0.000746	0.00511	CcSEcCtD
Ivacaftor—Mediastinal disorder—Topotecan—peripheral nervous system neoplasm	0.000727	0.00498	CcSEcCtD
Ivacaftor—Mediastinal disorder—Melphalan—peripheral nervous system neoplasm	0.000712	0.00488	CcSEcCtD
Ivacaftor—Upper respiratory tract infection—Alitretinoin—peripheral nervous system neoplasm	0.000704	0.00483	CcSEcCtD
Ivacaftor—Infestation NOS—Alitretinoin—peripheral nervous system neoplasm	0.000676	0.00463	CcSEcCtD
Ivacaftor—Infestation—Alitretinoin—peripheral nervous system neoplasm	0.000676	0.00463	CcSEcCtD
Ivacaftor—Breast disorder—Cisplatin—peripheral nervous system neoplasm	0.000675	0.00463	CcSEcCtD
Ivacaftor—Hyperaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000673	0.00462	CcSEcCtD
Ivacaftor—Aspartate aminotransferase increased—Cisplatin—peripheral nervous system neoplasm	0.000673	0.00461	CcSEcCtD
Ivacaftor—Nasopharyngitis—Cisplatin—peripheral nervous system neoplasm	0.000668	0.00458	CcSEcCtD
Ivacaftor—Hyperaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000623	0.00427	CcSEcCtD
Ivacaftor—Arthralgia—Topotecan—peripheral nervous system neoplasm	0.000598	0.0041	CcSEcCtD
Ivacaftor—Myalgia—Topotecan—peripheral nervous system neoplasm	0.000598	0.0041	CcSEcCtD
Ivacaftor—Unspecified disorder of skin and subcutaneous tissue—Topotecan—peripheral nervous system neoplasm	0.000594	0.00407	CcSEcCtD
Ivacaftor—Arthralgia—Isotretinoin—peripheral nervous system neoplasm	0.000593	0.00407	CcSEcCtD
Ivacaftor—Myalgia—Tretinoin—peripheral nervous system neoplasm	0.000593	0.00407	CcSEcCtD
Ivacaftor—Myalgia—Isotretinoin—peripheral nervous system neoplasm	0.000593	0.00407	CcSEcCtD
Ivacaftor—Arthralgia—Tretinoin—peripheral nervous system neoplasm	0.000593	0.00407	CcSEcCtD
Ivacaftor—Unspecified disorder of skin and subcutaneous tissue—Tretinoin—peripheral nervous system neoplasm	0.000589	0.00404	CcSEcCtD
Ivacaftor—Unspecified disorder of skin and subcutaneous tissue—Isotretinoin—peripheral nervous system neoplasm	0.000589	0.00404	CcSEcCtD
Ivacaftor—Myalgia—Melphalan—peripheral nervous system neoplasm	0.000585	0.00401	CcSEcCtD
Ivacaftor—Unspecified disorder of skin and subcutaneous tissue—Melphalan—peripheral nervous system neoplasm	0.000581	0.00399	CcSEcCtD
Ivacaftor—Connective tissue disorder—Vincristine—peripheral nervous system neoplasm	0.000574	0.00394	CcSEcCtD
Ivacaftor—Infection—Topotecan—peripheral nervous system neoplasm	0.000569	0.0039	CcSEcCtD
Ivacaftor—Tinnitus—Alitretinoin—peripheral nervous system neoplasm	0.000565	0.00388	CcSEcCtD
Ivacaftor—Infection—Tretinoin—peripheral nervous system neoplasm	0.000565	0.00387	CcSEcCtD
Ivacaftor—Infection—Isotretinoin—peripheral nervous system neoplasm	0.000565	0.00387	CcSEcCtD
Ivacaftor—Nervous system disorder—Topotecan—peripheral nervous system neoplasm	0.000562	0.00385	CcSEcCtD
Ivacaftor—Blood bilirubin increased—Epirubicin—peripheral nervous system neoplasm	0.000559	0.00383	CcSEcCtD
Ivacaftor—Nervous system disorder—Tretinoin—peripheral nervous system neoplasm	0.000558	0.00382	CcSEcCtD
Ivacaftor—Nervous system disorder—Isotretinoin—peripheral nervous system neoplasm	0.000558	0.00382	CcSEcCtD
Ivacaftor—Infection—Melphalan—peripheral nervous system neoplasm	0.000558	0.00382	CcSEcCtD
Ivacaftor—Skin disorder—Topotecan—peripheral nervous system neoplasm	0.000557	0.00382	CcSEcCtD
Ivacaftor—Skin disorder—Tretinoin—peripheral nervous system neoplasm	0.000552	0.00379	CcSEcCtD
Ivacaftor—Skin disorder—Isotretinoin—peripheral nervous system neoplasm	0.000552	0.00379	CcSEcCtD
Ivacaftor—Skin disorder—Melphalan—peripheral nervous system neoplasm	0.000545	0.00374	CcSEcCtD
Ivacaftor—Infestation NOS—Etoposide—peripheral nervous system neoplasm	0.000527	0.00361	CcSEcCtD
Ivacaftor—Infestation—Etoposide—peripheral nervous system neoplasm	0.000527	0.00361	CcSEcCtD
Ivacaftor—Mediastinal disorder—Vincristine—peripheral nervous system neoplasm	0.000527	0.00361	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Topotecan—peripheral nervous system neoplasm	0.000522	0.00358	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Tretinoin—peripheral nervous system neoplasm	0.000518	0.00355	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Isotretinoin—peripheral nervous system neoplasm	0.000518	0.00355	CcSEcCtD
Ivacaftor—Blood bilirubin increased—Doxorubicin—peripheral nervous system neoplasm	0.000517	0.00354	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Melphalan—peripheral nervous system neoplasm	0.000511	0.0035	CcSEcCtD
Ivacaftor—Connective tissue disorder—Cisplatin—peripheral nervous system neoplasm	0.000508	0.00348	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Topotecan—peripheral nervous system neoplasm	0.000495	0.00339	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Isotretinoin—peripheral nervous system neoplasm	0.000491	0.00336	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Tretinoin—peripheral nervous system neoplasm	0.000491	0.00336	CcSEcCtD
Ivacaftor—Myalgia—Dactinomycin—peripheral nervous system neoplasm	0.000485	0.00332	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Melphalan—peripheral nervous system neoplasm	0.000484	0.00332	CcSEcCtD
Ivacaftor—Tinnitus—Cisplatin—peripheral nervous system neoplasm	0.000482	0.0033	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Topotecan—peripheral nervous system neoplasm	0.000469	0.00321	CcSEcCtD
Ivacaftor—Mediastinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000466	0.00319	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Tretinoin—peripheral nervous system neoplasm	0.000465	0.00319	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Isotretinoin—peripheral nervous system neoplasm	0.000465	0.00319	CcSEcCtD
Ivacaftor—Infection—Dactinomycin—peripheral nervous system neoplasm	0.000462	0.00316	CcSEcCtD
Ivacaftor—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.000453	0.00311	CcSEcCtD
Ivacaftor—Arthralgia—Alitretinoin—peripheral nervous system neoplasm	0.000449	0.00308	CcSEcCtD
Ivacaftor—Myalgia—Alitretinoin—peripheral nervous system neoplasm	0.000449	0.00308	CcSEcCtD
Ivacaftor—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.000449	0.00308	CcSEcCtD
Ivacaftor—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.000449	0.00308	CcSEcCtD
Ivacaftor—Unspecified disorder of skin and subcutaneous tissue—Alitretinoin—peripheral nervous system neoplasm	0.000446	0.00306	CcSEcCtD
Ivacaftor—Myalgia—Vincristine—peripheral nervous system neoplasm	0.000433	0.00297	CcSEcCtD
Ivacaftor—Infection—Alitretinoin—peripheral nervous system neoplasm	0.000428	0.00293	CcSEcCtD
Ivacaftor—Mediastinal disorder—Etoposide—peripheral nervous system neoplasm	0.000427	0.00292	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Dactinomycin—peripheral nervous system neoplasm	0.000423	0.0029	CcSEcCtD
Ivacaftor—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.000423	0.0029	CcSEcCtD
Ivacaftor—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.000419	0.00287	CcSEcCtD
Ivacaftor—Infection—Vincristine—peripheral nervous system neoplasm	0.000412	0.00283	CcSEcCtD
Ivacaftor—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.000407	0.00279	CcSEcCtD
Ivacaftor—Hypoglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000393	0.00269	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000393	0.00269	CcSEcCtD
Ivacaftor—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000392	0.00269	CcSEcCtD
Ivacaftor—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000389	0.00267	CcSEcCtD
Ivacaftor—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000389	0.00267	CcSEcCtD
Ivacaftor—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000384	0.00263	CcSEcCtD
Ivacaftor—Myalgia—Cisplatin—peripheral nervous system neoplasm	0.000383	0.00263	CcSEcCtD
Ivacaftor—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.00038	0.00261	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.00038	0.0026	CcSEcCtD
Ivacaftor—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000379	0.0026	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000378	0.00259	CcSEcCtD
Ivacaftor—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000376	0.00258	CcSEcCtD
Ivacaftor—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000376	0.00258	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000372	0.00255	CcSEcCtD
Ivacaftor—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000367	0.00252	CcSEcCtD
Ivacaftor—Infection—Cisplatin—peripheral nervous system neoplasm	0.000365	0.0025	CcSEcCtD
Ivacaftor—Hypoglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000364	0.00249	CcSEcCtD
Ivacaftor—Rash—Topotecan—peripheral nervous system neoplasm	0.000361	0.00248	CcSEcCtD
Ivacaftor—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000361	0.00247	CcSEcCtD
Ivacaftor—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.00036	0.00247	CcSEcCtD
Ivacaftor—Headache—Topotecan—peripheral nervous system neoplasm	0.000359	0.00246	CcSEcCtD
Ivacaftor—Rash—Tretinoin—peripheral nervous system neoplasm	0.000358	0.00246	CcSEcCtD
Ivacaftor—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000358	0.00246	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000358	0.00246	CcSEcCtD
Ivacaftor—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000358	0.00246	CcSEcCtD
Ivacaftor—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000358	0.00246	CcSEcCtD
Ivacaftor—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000357	0.00244	CcSEcCtD
Ivacaftor—Headache—Tretinoin—peripheral nervous system neoplasm	0.000356	0.00244	CcSEcCtD
Ivacaftor—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000356	0.00244	CcSEcCtD
Ivacaftor—Rash—Melphalan—peripheral nervous system neoplasm	0.000354	0.00243	CcSEcCtD
Ivacaftor—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000354	0.00242	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000352	0.00242	CcSEcCtD
Ivacaftor—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000348	0.00239	CcSEcCtD
Ivacaftor—Breast disorder—Epirubicin—peripheral nervous system neoplasm	0.000347	0.00238	CcSEcCtD
Ivacaftor—Aspartate aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000345	0.00237	CcSEcCtD
Ivacaftor—Nasopharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000343	0.00235	CcSEcCtD
Ivacaftor—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000341	0.00233	CcSEcCtD
Ivacaftor—Nausea—Topotecan—peripheral nervous system neoplasm	0.00034	0.00233	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.00034	0.00233	CcSEcCtD
Ivacaftor—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000338	0.00231	CcSEcCtD
Ivacaftor—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000338	0.00231	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000334	0.00229	CcSEcCtD
Ivacaftor—Infection—Etoposide—peripheral nervous system neoplasm	0.000334	0.00229	CcSEcCtD
Ivacaftor—Nausea—Melphalan—peripheral nervous system neoplasm	0.000333	0.00228	CcSEcCtD
Ivacaftor—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000328	0.00225	CcSEcCtD
Ivacaftor—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000327	0.00224	CcSEcCtD
Ivacaftor—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	0.000321	0.0022	CcSEcCtD
Ivacaftor—Aspartate aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.00032	0.00219	CcSEcCtD
Ivacaftor—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000318	0.00218	CcSEcCtD
Ivacaftor—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000317	0.00218	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000317	0.00217	CcSEcCtD
Ivacaftor—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.000308	0.00211	CcSEcCtD
Ivacaftor—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000296	0.00203	CcSEcCtD
Ivacaftor—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000296	0.00203	CcSEcCtD
Ivacaftor—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000295	0.00202	CcSEcCtD
Ivacaftor—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000293	0.00201	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.00029	0.00199	CcSEcCtD
Ivacaftor—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000285	0.00195	CcSEcCtD
Ivacaftor—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000285	0.00195	CcSEcCtD
Ivacaftor—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000284	0.00195	CcSEcCtD
Ivacaftor—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000276	0.00189	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000275	0.00189	CcSEcCtD
Ivacaftor—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000275	0.00188	CcSEcCtD
Ivacaftor—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000274	0.00187	CcSEcCtD
Ivacaftor—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000274	0.00187	CcSEcCtD
Ivacaftor—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000272	0.00186	CcSEcCtD
Ivacaftor—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000271	0.00186	CcSEcCtD
Ivacaftor—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00027	0.00185	CcSEcCtD
Ivacaftor—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000266	0.00182	CcSEcCtD
Ivacaftor—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000266	0.00182	CcSEcCtD
Ivacaftor—Rash—Vincristine—peripheral nervous system neoplasm	0.000262	0.00179	CcSEcCtD
Ivacaftor—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000262	0.00179	CcSEcCtD
Ivacaftor—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000261	0.00179	CcSEcCtD
Ivacaftor—Headache—Vincristine—peripheral nervous system neoplasm	0.00026	0.00178	CcSEcCtD
Ivacaftor—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000256	0.00175	CcSEcCtD
Ivacaftor—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000251	0.00172	CcSEcCtD
Ivacaftor—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000247	0.0017	CcSEcCtD
Ivacaftor—Nausea—Vincristine—peripheral nervous system neoplasm	0.000247	0.00169	CcSEcCtD
Ivacaftor—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000246	0.00169	CcSEcCtD
Ivacaftor—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000241	0.00165	CcSEcCtD
Ivacaftor—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000239	0.00164	CcSEcCtD
Ivacaftor—Rash—Cisplatin—peripheral nervous system neoplasm	0.000231	0.00159	CcSEcCtD
Ivacaftor—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000231	0.00159	CcSEcCtD
Ivacaftor—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.00023	0.00158	CcSEcCtD
Ivacaftor—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000229	0.00157	CcSEcCtD
Ivacaftor—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000222	0.00152	CcSEcCtD
Ivacaftor—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000221	0.00152	CcSEcCtD
Ivacaftor—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000218	0.00149	CcSEcCtD
Ivacaftor—Rash—Etoposide—peripheral nervous system neoplasm	0.000212	0.00145	CcSEcCtD
Ivacaftor—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000212	0.00145	CcSEcCtD
Ivacaftor—Headache—Etoposide—peripheral nervous system neoplasm	0.000211	0.00144	CcSEcCtD
Ivacaftor—Nausea—Etoposide—peripheral nervous system neoplasm	0.0002	0.00137	CcSEcCtD
Ivacaftor—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000197	0.00135	CcSEcCtD
Ivacaftor—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000197	0.00135	CcSEcCtD
Ivacaftor—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000195	0.00134	CcSEcCtD
Ivacaftor—Infection—Epirubicin—peripheral nervous system neoplasm	0.000187	0.00128	CcSEcCtD
Ivacaftor—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000185	0.00127	CcSEcCtD
Ivacaftor—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000183	0.00126	CcSEcCtD
Ivacaftor—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000182	0.00125	CcSEcCtD
Ivacaftor—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000182	0.00125	CcSEcCtD
Ivacaftor—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000181	0.00124	CcSEcCtD
Ivacaftor—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000173	0.00119	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000172	0.00118	CcSEcCtD
Ivacaftor—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000171	0.00117	CcSEcCtD
Ivacaftor—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000169	0.00116	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000163	0.00112	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000159	0.00109	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000154	0.00106	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000151	0.00103	CcSEcCtD
Ivacaftor—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000149	0.00102	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000143	0.000978	CcSEcCtD
Ivacaftor—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.000945	CcSEcCtD
Ivacaftor—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000129	0.000884	CcSEcCtD
Ivacaftor—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000125	0.000855	CcSEcCtD
Ivacaftor—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.000818	CcSEcCtD
Ivacaftor—Rash—Epirubicin—peripheral nervous system neoplasm	0.000119	0.000815	CcSEcCtD
Ivacaftor—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000119	0.000814	CcSEcCtD
Ivacaftor—Headache—Epirubicin—peripheral nervous system neoplasm	0.000118	0.00081	CcSEcCtD
Ivacaftor—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.000791	CcSEcCtD
Ivacaftor—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000768	CcSEcCtD
Ivacaftor—Rash—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000754	CcSEcCtD
Ivacaftor—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000753	CcSEcCtD
Ivacaftor—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000749	CcSEcCtD
Ivacaftor—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.00071	CcSEcCtD
